ozempic or retatrutide Promises Big Weight Loss, but Safety Remains a Question The Truth About GLP-1 &

The study was sponsored by Eli Lilly and Company, the manufacturer of orforglipron and the injectable GLP-1 tirzepatide

The European Medicines Agency reached a similar conclusion in 2024, confirming that while a connection could not be proven, continued vigilance was warranted

In summary, although the application of GLP-1RA in treating tumors is still in the exploratory stage, it has shown significant effects and certain additional health benefits in the treatment of diabetes

[8] [9] Currently, NHS England advises that GLP-1 receptor agonists should be prioritised for patients with type 2 diabetes due to supply constraints

PlexusDx exclusively sources compounded semaglutide from licensed 503A pharmacies, ensuring that every medication is prepared specifically for an individual patient with a valid prescription